Background {#Sec1}
==========

Biliary mucinous cystic neoplasms (BMCNs) are rare liver tumors that pose a considerable diagnostic challenge, as they can mimic various other liver lesions. Accurate pre-operative diagnosis may be difficult. A thorough understanding of the characteristic features of BMCNs and a high index of suspicion are essential to minimize the risk of malignant transformation or recurrence.

Herein, we present an interesting case of a 37-year-old female with a biliary mucinous cystic neoplasm mimicking a hydatid cyst. We review the current literature on BMCNs, including clinical presentation, diagnostic investigations (with an emphasis on radiological findings) and surgical management.

Case presentation {#Sec2}
=================

An otherwise healthy 37-year-old Tunisian woman presented to the emergency department with a 3--4 month history of right upper quadrant pain. She also reported general malaise and a 2--3 kg weight loss. She denied any jaundice, fever or infectious symptoms. She had been living in Tunisia up until the previous year, and had been exposed to dogs and sheep. On physical examination, she had mild right upper quadrant tenderness, without peritoneal signs. Computed tomography (CT) scan revealed a 7.1 × 6.5 × 10.7 cm complex, multi-loculated cystic mass with partially calcified septations, partially embedded within the liver (segments V/VIII) and causing deviation of the right portal vein (Fig. [1](#Fig1){ref-type="fig"}). There was no biliary dilatation or portal venous thrombosis. White blood cell count (5.5 × 10\^9/L), eosinophil count (0.2 × 10\^9/L) and liver function tests (Bilirubin 6, ALT 19, AST 19, ALP 48, GGT 15) were within normal limits. Tumor markers (including Ca19--9) and serum IgE level were not performed. She was discharged with outpatient hepatobiliary follow-up.Fig. 1CT scan with oral and intravenous contrast in axial (1a and 1b) and coronal (1c and 1d) views, demonstrating a multi-loculated cystic mass embedded within segments V and VIII of the liver and causing deviation of the right portal vein. Arrows pointing towards the partially calcified septations

Given her history of proximity to livestock in an endemic area, the diagnosis of a hydatid cyst was strongly favored. However, echinococcosis and amoebiasis serologies were both negative. At the multidisciplinary tumor board discussion, the diagnostic value of a pre-operative biopsy was weighed against the risk of potential seeding. The Tropical Disease team deemed this lesion to be most likely a hydatid cyst, corresponding to a category CE 3A cyst according to the WHO classification \[[@CR1]\]. Although only the minority (5--20%) of CE 3 cysts are sero-negative \[[@CR2]\], the recommendation was to proceed with surgical resection, following a one-week pre-operative course of albendazole.

She underwent a right hepatectomy through a right subcostal incision considering the size of the lesion and its proximity to the right portal vein. Intra-operatively, the cyst appeared white, quite thickened, and intimately associated with the portal vein. It was opened on the back table and found to contain murky fluid as well as another cyst within, which was originally thought to represent a daughter cyst (Fig. [2](#Fig2){ref-type="fig"}). Her postoperative course was unremarkable, and she was discharged home on postoperative day 5. An abdominal ultrasound performed 6 months post-operatively showed no residual disease.Fig. 2Gross morphology of the biliary mucinous cystic neoplasm (2a, 2b and 2c)

Final pathology surprisingly revealed a biliary mucinous cystic neoplasm, which was completely excised with negative margins. It contained ovarian-type stroma and dystrophic calcifications. The cyst wall was composed of a single layer of cylindrical to flattened cuboidal epithelium (Fig. [3](#Fig3){ref-type="fig"}a). Cytokeratin 19, an epithelial marker, was positive (would be negative in hydatid cyst) (Fig. [3](#Fig3){ref-type="fig"}b). The estrogen receptor protein and CD10 were expressed, highlighting the ovarian-type stroma, which is typically seen in BMCN (Fig. [3](#Fig3){ref-type="fig"}c and d). Vimentin and PAX-8 were negative, thereby excluding gynecological origin. The remainder of the liver parenchyma and gallbladder were otherwise normal.Fig. 3Light microscopy of the biliary mucinous cystic neoplasm showing the ovarian-type stroma with hematoxylin and eosin stain (3a). Immunohistochemical staining using Cytokeratin 19 (3b), estrogen receptor protein (3c) and CD10 (3d) highlighting the epithelium and ovarian stroma present in cystadenomas

Discussion and Conclusion {#Sec3}
=========================

Biliary mucinous cystic neoplasms (BMCNs) are rare cystic lesions which predominantly occur in the liver, but can occasionally arise in the extra-hepatic biliary system. They account for less than 5% of non-parasitic liver cysts \[[@CR3]\]. There are only a few hundred cases reported in the literature (Table [1](#Tab1){ref-type="table"}). BMCNs occur almost exclusively (85--95%) in middle-aged females \[[@CR7], [@CR11]\]. Typically, patients are asymptomatic or present with an insidious onset of non-specific symptoms, which renders the clinical diagnosis, and distinction from hydatid cyst, challenging. However, a history of recent visit in an endemic area for hydatid disease can be an important clue. Acute onset of pain is usually secondary to intra-cystic hemorrhage or cyst rupture \[[@CR10]\]. Contrary to hydatid cysts, BMCNs have been reported to increase in size during pregnancy and with oral contraceptives, suggesting hormonal dependency \[[@CR5], [@CR8]\].Table 1Review of contemporary published case series on biliary mucinous cystic neoplasms with more than 10 casesNSexAge (years)Size cm (mean)Previous interventionOperative Procedure and recurrencesFollow-upVogt et al. (2005) \[[@CR4]\]18*F* = 184812.5 (7--22)10 patients (55%)Enucleation \[[@CR5]\]Mean: 37 monthsPartial excision \[[@CR6]\]Sectionectomy \[[@CR7]\] -- *1 recurrence at 3 years3/15 recurrences*Aspiration \[[@CR8]\]Hepatectomy \[[@CR2]\]Roux-en-Y \[[@CR1]\]Partial resection \[[@CR7]\] -- *2 recurrences at 13 months and 10 years*Thomas et al. (2005) \[[@CR9]\]18 BCA1 BCAC*F* = 18*M* = 14810.9 ± 4.48 patients (42%Lobectomy \[[@CR6]\]Mean: 3.5 ± 4.2 yearsAspiration or drainage \[[@CR6]\]Enucleation \[[@CR10]\]No mortality or recurrenceFenestration \[[@CR11]\]Bisegmentectomy \[[@CR2]\]Roux-en-Y \[[@CR1]\]Non-anatomic resection \[[@CR1]\]Fenestration + fulguration \[[@CR1]\]Daniels et al. (2006) \[[@CR12]\]12*F* = 1250.512.7 (6.5--25)5 patients (42%)Enucleation + complete resection \[[@CR8]\]Unknown duration of follow-upDrainage \[[@CR7]\]Enucleation \[[@CR7]\]No mortality or recurrenceRoux-en-Y \[[@CR1]\]Complete resection \[[@CR1]\]Choi et al. (2010) \[[@CR13]\]17*F* = 175710.1 ± 6.6UnknownHepatectomy \[[@CR14]\]N/AUnroofing or marsupialization \[[@CR3]\]Erdogan et al. (2010) \[[@CR15]\]12 BCA3 BCAC*F* = 13*M* = 2458.4 ± 5.3 (3--19)UnknownEnucleation \[[@CR6]\]No early post-operative mortalityHepatectomy \[[@CR10]\]Seo et al. (2010) \[[@CR16]\]13*F* = 12*M* = 155.3± 11.412.9 ± 6.3NoneComplete resection \[[@CR17]\] -- segmentectomies, lobectomies or enucleationMedian: 29 monthsNo mortality or recurrenceSang et al. (2011) \[[@CR18]\]19*F* = 17*M* = 244.2± 14.413.0 ± 8.15 patients (26%)Hemihepatectomy \[[@CR11]\] -- *1 death from widespread metastasis at 8 months*Median: 22.5 monthsAspiration \[[@CR10]\]Sectionectomy \[[@CR11]\]*1/19 mortality*Fenestration \[[@CR7]\]Segmentectomy \[[@CR11]\]No recurrenceEnucleation \[[@CR3]\]Fenestration \[[@CR1]\]Martel et al. (2012) \[[@CR19]\]11 BCA2 BCAC*F* = 12*M* = 151± 15.912.4 ± 4.6NoneEnucleation \[[@CR10]\]Median: 23.1 monthsUnroofing \[[@CR7]\] -- *1 death from MI 13 months post-op, 1 recurrence within 40 months1/13 mortality1/13 recurrence*Liver resection \[[@CR3]\]Pillai et al. (2012) \[[@CR8]\]13*F* = 11*M* = 246(23--34)7 (54%)Hepatectomy \[[@CR11]\]Median: 22 monthsPartial cystoperi-Segmentectomy \[[@CR11]\]No mortality or recurrencecystectomies \[[@CR11]\]Enucleation \[[@CR3]\]Marsupialisaton \[[@CR1]\]Fenestration \[[@CR1]\]Ratti et al. (2012) \[[@CR20]\]12*F* = 1245± 9.4N/A6/12 (50%) ➔ Unroofing followed by complete resection after post-op diagnosis (median delay of 31 days)Hepatectomy \[[@CR6]\]Median: 16 monthsLobectomy \[[@CR3]\]No mortality or recurrenceWang et al. (2012) \[[@CR21]\]20*F* = 19*M* = 144.2 ± 13.113.0 (4.4--32)UnknownLiver resection \[[@CR22]\]N/AChen et al. (2014) \[[@CR23]\]35 BCA4 BCAC*F* = 30*M* = 953.7± 14.5N/ANoneEnucleation \[[@CR24]\]Median: 20.5 monthsHepatectomy \[[@CR25]\]*1/4 recurrence in a patient with BCAC*No mortality or recurrence for BCAWang et al. (2014) \[[@CR26]\]13 BCA1 BCAC*F* = 11*M* = 34810.4 ± 6.3NoneLobectomy \[[@CR8]\]Median: 54 months*1/1 recurrence for BCAC 2 years post-op*Hepatectomy \[[@CR2]\]No mortality or recurrence for BCAPartial hepatic resection \[[@CR7]\]Non-anatomic resection \[[@CR1]\]Albores-Saavedra et al. (2015) \[[@CR27]\]18 BCA2 BCAC*F* = 18*M* = 238.211 (4--29)NoneEnucleation \[[@CR4]\]Range 2--11 yearsLobectomy \[[@CR10]\]*3/15 recurrences for BCA patients*Whipple resection \[[@CR2]\]Local excision \[[@CR2]\]Lee et al. (2015) \[[@CR28]\]19*F* = 16*M* = 3578.5 (2.5--21)NoneComplete resection: anatomic or enucleation \[[@CR29]\]Median: 51.3 monthsPartial resection: fenestration, marsupialization, partial excision \[[@CR5]\] -- *5 (62.5%) recurrences, 1 death 32 days postop*Median DFS: 3.7 months (for partial resection)Arnaoutakis et al. (2015) \[[@CR30]\]221*F* = 199*M* = 2251.2± 15.1Median: 10.0IQR: 7--13Cyst aspiration (19.8%)Sclerosis (2%)Partial hepatectomy (116, 52.5%)10-year follow-up: 84% patients alive with BCA31/221 (16.7%)Hepatectomy (70, 31.7%) -- *15/186 (8.1%) recurrences*Total: 248 BCAC: 27Unroofing/partial excision (34, 15.4%) -- *16 (45.6%) recurrences*recurrences50 (22.6%) early post-operative complicationsLiver transplant (1, 0.4%)*BCA* Biliary cystadenoma (biliary mucinous cystic neoplasia), *BCAC* Biliary cystadenocarcinoma (biliary mucinous cystic neoplasia with invasive carcinoma), *DFS* Disease-free survival, *OS* Overall survival, *RFS* Relapse-free survival, *F* Female, *M* Male, *MI* Myocardial Infarction, *IQR* Inter-quartile rangeFull articles are available via PubMed and originally in EnglishWhen possible, biliary cystadenocarcinoma cases were removed from analysis given focus of this manuscript on biliary cystadenoma

Biliary mucinous cystic neoplasms are histologically divided into two types, depending on the presence of mesenchymal stroma, which is a subepithelial stroma resembling ovarian stroma \[[@CR11]\]. BMCNs with mesenchymal stroma are considered to carry a favorable prognosis, and are exclusively seen in women \[[@CR5]\]. Those without mesenchymal stroma are more susceptible to malignant transformation and are associated with a poorer prognosis. The cyst fluid may be mucinous or serous. Blood-tinged cyst fluid raises concern for a malignant component \[[@CR6]\]. Cyst sizes are largely variable, with reports ranging from 1.5 to 35 cm \[[@CR4], [@CR29]\]. The differential diagnosis of BMCN includes hydatid cysts, simple liver cysts, abscesses, hematomas and mucinous cystic neoplasms with associated invasive carcinoma (cystadenocarcinomas) \[[@CR3]\]. Differentiating BMCN from these other entities is critical, in light of the high recurrence rate if incompletely excised, and potential for malignant transformation.

Radiological findings {#Sec4}
---------------------

Ultrasonography (US), CT and magnetic resonance imaging (MRI) are the most commonly used imaging modalities in the workup of BMCN \[[@CR31]\]. They typically appears as a multi-loculated cyst with a well-defined, thick capsule and internal septations. Solid papillary projections, internal septae and wall enhancement upon contrast administration are other characteristic features \[[@CR17]\]. While hydatid cysts preferentially affect the right lobe, a lesion within the left liver is more suggestive of BMCN \[[@CR14], [@CR17], [@CR29]\]. Upstream dilatation of adjacent intra-hepatic biliary radicles can occur secondary to mass effect. Demonstrable communication of the cyst with the biliary system is a specific, albeit rarely observed, finding \[[@CR32]\]. Therefore, pre-operative ERCP (endoscopic retrograde cholangiopancreatography) and PTC (percutaneous transhepatic cholangiography or cystography) can potentially help in the diagnosis of cystadenoma if a communication is seen. It is especially important if a patient presents with jaundice since it can reveal biliary compression by the tumor \[[@CR33]\]. Finally, intra-operative cholangiography (IOC), while also allowing fluid sampling for cytology, may be useful to diagnose extrahepatic biliary tree cystadenoma \[[@CR25]\]. Nevertheless, most BMCNs will have no identifiable biliary connection, even intra-operatively \[[@CR6]\].

The presence of an irregular and thickened cystic wall, hypervascular mural solid nodules, thick calcifications and papillary projections may suggest an increased risk of malignancy \[[@CR34]\]. However, imaging findings cannot reliably differentiate cystadenoma from cystadenocarcinoma. Despite certain radiological findings which may favor the diagnosis of BMCN, the sensitivity of pre-operative diagnosis remains low (30%). As such, a high index of suspicion should be maintained when imaging findings are non-diagnostic.

The radiological appearance of hepatic hydatid disease is also quite variable. On US, the cyst wall is usually seen as double echogenic lines separated by a hypo-echogenic layer. Calcifications can be present in the cyst wall, although internal calcifications are also seen. Hydatid sand may be visualized as small echogenic foci falling to the most dependent portion of the cyst (i.e. snowstorm sign) \[[@CR22], [@CR35]\]. Daughter cysts are another feature of hydatid disease. They appear as cysts within a cyst and are usually separated by multiple septa in a honeycomb pattern \[[@CR22]\]. Occasionally, membranes of broken daughter vesicles appear as "serpentine linear structures" inside the hydatid matrix; this feature is highly specific for hydatid disease \[[@CR36]\]. CT findings are overall similar to the ones observed with US. On T2 MRI, hydatid cysts may have a low signal intensity rim, which has been proposed as a characteristic feature of this disease \[[@CR36]\].

Adjunct investigations {#Sec5}
----------------------

Core needle biopsy is not routinely recommended, because of its low diagnostic accuracy and the risk of seeding and dissemination, in case of malignancy \[[@CR24]\]. In addition, biopsy should be avoided when the diagnosis of a hydatid cyst remains a possibility, as hydatid cyst rupture is associated with significant risk of anaphylaxis \[[@CR37]\]. While elevated CEA and Ca-19-9 levels in the serum or cyst fluid may be helpful, a normal level does not exclude BMCN \[[@CR38]\]. In fact, some case series report no significant difference between these levels when compared to simple hepatic cysts \[[@CR13]\]. Serological tests may be useful in the workup of a suspected echinococcal cyst, although diagnosis may prove challenging in the face of a weak immune response \[[@CR39]\].

Management {#Sec6}
----------

Management of biliary mucinous cystic neoplasms is dictated by two key concerns. First, if misdiagnosed as a simple cyst or a hydatid cyst, incomplete excision (such as deroofing, marsupialization or partial resection) may be undertaken. Incomplete excision of BMCN is associated with a high recurrence rate, with some authors reporting recurrence rates over 90% \[[@CR6], [@CR40]\]. Thus, complete excision is indicated, and recurrence of a hepatic cyst following partial resection should raise suspicion for a BMCN \[[@CR9]\]. In the case of hepatic hydatid disease, surgical management is recommended to avoid complications such as exophytic growth leading to pressure or mass effects on nearby structures (such as bile ducts, portal or hepatic veins), cyst rupture leading to peritonitis, bacterial infection which can result in liver abscesses, transdiaphragmatic thoracic involvement as well as hematogenous dissemination \[[@CR14]\]. A pre-operative course of anthelmintics (e.g. albendazole) is recommended to achieve sterilization and to reduce the risk of recurrence post-operatively \[[@CR41], [@CR42]\].

Second, because differentiating BMCN from cystadenocarcinoma pre-operatively is exceedingly difficult, complete surgical resection remains the gold standard \[[@CR38], [@CR43]\]. The risk of malignant transformation to cystadenocarcinoma supports the role of surgical resection. Lewis et al. published a series of 15 BMCNs for which formal resection was undertaken, and reported few complications and no recurrences \[[@CR44]\]. Table [1](#Tab1){ref-type="table"} summarizes the major characteristics of the largest contemporary case series on BMCNs. It emphasizes that complete resection is a safe and efficacious method to treat cystadenoma with good outcomes and low risk of recurrence. When the diagnosis is unclear pre-operatively between hydatid cyst and BMCN, we would recommend complete resection, as it would treat both diseases, and minimize the risk of recurrence.

Enucleation is a viable alternative in cases in which formal resection would be technically difficult or associated with excessive morbidity \[[@CR45], [@CR46]\]. Although only small case series are available, some have shown comparable results compared to formal hepatectomy, with few recurrences \[[@CR9], [@CR47]\]. However, given the large size of these lesions and the resulting distorted anatomy, enucleation remains technically challenging and must be approached with caution.

Finally, given the high rate of recurrence and the potential risk for malignant transformation \[[@CR48]\], surveillance imaging with ultrasound or CT scan at regular intervals is recommended post-operatively \[[@CR20], [@CR49]\].

Discussion {#Sec7}
==========

Biliary mucinous cystic neoplasms are rare liver neoplasms, which may strongly mimic a hydatid cyst in patients with a contributory history. Pre-operative differentiation on the basis of radiological, biochemical and serological features is often unreliable. Suspicious multilocular cystic lesions should be managed with complete surgical resection, as conservative techniques are associated with high recurrence rates in cases of BMCN. Considering the potential for malignant transformation, periodical surveillance imaging is recommended in the post-operative period.
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